Mr. Pascual is the founder of Pascual, LLC, a specialty firm that provides high-level strategic advice and general counsel services to a select group of clients. Prior to founding Pascual LLC in 2017, Mr. Pascual practiced for almost 30 years at three of the country’s best law firms, most recently as a ten-year partner of Paul Hastings LLP, where he chaired the Atlanta corporate group, served as Atlanta office chair, and served on the firm’s Policy Committee. Prior to Paul Hastings, Mr. Pascual was a partner at Kilpatrick Stockton, LLP in Atlanta and was involved in firm management as member for many years of various management committees, including the firm’s Executive Committee. In his career, Mr. Pascual has represented numerous clients from inception to IPOs and billion-dollar exit transactions, has led hundreds of private and public investment and merger and acquisition transactions and been a trusted advisor and board member to many businesses. Rey has also been an early investor in many successful businesses throughout the years.

Mr. Pascual is a Life Trustee of Syracuse University and served four-year terms as Vice Chair of the Board and Chair of the Student Affairs Committee as well as an eight-year term as member of the University’s Executive Committee. He received a Chancellor’s Citation for Distinguished Service in Law in 2002. He has also served on the boards of many well-known not-for-profit organizations in Atlanta, Georgia, including the Metropolitan Atlanta Chamber of Commerce, the Atlanta History Center, the Atlanta Convention & Visitors Bureau and the Woodruff Arts Center.

Mr. Pascual has been recognized numerous times as a “Super Lawyer,” “Best Lawyer in America,” “Leading Corporate Lawyer,” and “Who’s Who” in the Atlanta Legal Community.

Mr. Pascual graduated, cum laude, from Syracuse University and magna cum laude from the Creighton University School of Law.

Prior to joining VIVEX Biologics, Mr. Maye spent close to 20 years with LifeNet, a regenerative medicine company based in Virginia Beach. During his time there, he served in various roles of increasing responsibility throughout the organization, including Vice President of Quality Systems.

In addition to his role at VIVEX Biologics, Mr. Maye serves as the Chairperson of the American Association of Tissue Banks’ Standards Committee, where he leads a collaboration to develop current operating standards for the industry.

Mr. Maye holds a Bachelor of Science degree in Medical Technology from Old Dominion University.

In 2002, Mr. Anderson founded Atlanta-based T2MED, Inc., one of the Southeast’s most innovative private companies in the growing spinal device market. In 2008, he merged T2 into Amendia, Inc. as one of its founding partners. With Mr. Anderson as the President of its Sales and Marketing group, Amendia grew to over $85 million in sales before being acquired by private equity for $190 million. In December 2012, Mr. Anderson licensed a unique stem cell lineage from the University of Miami for potential use in general orthopedics. In March of 2013, VIVEX Biologics was spun out from Amendia as a freestanding entity.

In November 2014, Mr. Anderson was instrumental in the acquisition of the University of Miami Tissue Bank, the oldest and one of the most prestigious human tissue facilities in the world. UMTB immediately became VIVEX Biologics, a fully owned subsidiary of VIVEX Biologics, Inc. In July of 2019, Mr. Anderson transitioned from his role as President and CEO to the role of Vice Chairman. He remains a member of the Board of Directors. Through his leadership and innovation, VIVEX Biologics has grown to become a leading tissue and cell therapy company with scientifically based technologies, an unsurpassed patent portfolio, and significant revenue in the spine and orthopedic space.

Throughout his career, Mr. Anderson has partnered with some of the medical industry’s top experts in the areas of general orthopedics, spine surgery, sports medicine, cardiovascular surgery, ophthalmic surgery, and oncology. He is a member of several other professional organizations and advisory boards, including the Advisory Committee for Surgical Technology at Gwinnett Tech in Lawrenceville, Georgia.

Mr. Ellis serves as the Chief Executive Officer and Chairman of Ellis Capital, a consulting and investment firm primarily focused on the media, technology, healthcare, and fintech industries. He primarily manages acquisitions, strategic relationships, and fundraising for his companies, but has also been integrally involved in sales, operations, and strategic planning. He has managed multiple high growth companies and achieved significant returns for his investors.

Mr. Ellis previously founded and served as Chief Executive Officer of Act III Broadcasting, and Ellis Communications. He was a founding investor and board member of WebMD, and Amendia.

Mr. Ellis holds a Bachelor of Arts in Economics and a Master of Business Administration from the Darden Graduate School of Business Administration at the University of Virginia.